Annals of Hematology : Impact Factor & More
eISSN: 1432-0584pISSN: 0939-5555
Share this on:
Key Metrics
CiteScore 
5.2
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Hematology
SNIP
1.17
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Annals of Hematology
Annals of Hematology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1950 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Annals of Hematology
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group.
- 13 May 2026
- Annals of hematology
Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort.
- 13 May 2026
- Annals of hematology
Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).
- 12 May 2026
- Annals of hematology
Patients with steroid-refractory gastrointestinal aGVHD respond to ROCK2 inhibitor rapidly.
- 12 May 2026
- Annals of hematology
Factor VII Padua: a systematic review of reported cases, diagnosis, clinical manifestations, and management strategies.
- 12 May 2026
- Annals of hematology
Anti-CD3/CD20 bispecific antibodies as salvage therapy after CAR-T failure in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis.
- 12 May 2026
- Annals of hematology
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group.
- 13 May 2026
- Annals of hematology
Expanding the genetic spectrum of hereditary spherocytosis: novel mutations and phenotypic heterogeneity from a 55-patient cohort.
- 13 May 2026
- Annals of hematology
Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).
- 12 May 2026
- Annals of hematology
Patients with steroid-refractory gastrointestinal aGVHD respond to ROCK2 inhibitor rapidly.
- 12 May 2026
- Annals of hematology
Factor VII Padua: a systematic review of reported cases, diagnosis, clinical manifestations, and management strategies.
- 12 May 2026
- Annals of hematology
Anti-CD3/CD20 bispecific antibodies as salvage therapy after CAR-T failure in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis.
- 12 May 2026
- Annals of hematology
FAQs on Annals of Hematology
How long has Annals of Hematology been actively publishing? 
What is the publishing frequency of Annals of Hematology?
How many articles did Annals of Hematology publish last year?
What is the eISSN & pISSN for Annals of Hematology?
What is Citescore for Annals of Hematology?
What is SNIP score for Annals of Hematology?
What is the SJR for Annals of Hematology?
Who is the publisher of Annals of Hematology?
